These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 5761075)

  • 1. The standardization of the prothrombin time for the control of anticoagulant therapy.
    Biggs R
    Thromb Diath Haemorrh Suppl; 1968; 35():87-92. PubMed ID: 5761075
    [No Abstract]   [Full Text] [Related]  

  • 2. Fourth report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy.
    Denson KW
    Thromb Diath Haemorrh Suppl; 1968; 35():197-208. PubMed ID: 5761492
    [No Abstract]   [Full Text] [Related]  

  • 3. Standardisation of the one-stage prothrombin time test for the control of anticoagulant therapy: the availability and use of thromboplastin reference preparations.
    Nord Med; 1971 Oct; 86(40):1154-5. PubMed ID: 5167204
    [No Abstract]   [Full Text] [Related]  

  • 4. Standardization of the one-stage prothrombin time test for the control of anticoagulant therapy: availability and use of thromboplastin reference preparations.
    Biggs R; Bangham DR
    Br Med J; 1971 Aug; 3(5772):470-1. PubMed ID: 5105905
    [No Abstract]   [Full Text] [Related]  

  • 5. Third report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy.
    Biggs R; Denson KW
    Thromb Diath Haemorrh Suppl; 1967; 26():445-50. PubMed ID: 6064876
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulant activity of Heraclenin.
    Mishra KC; Sharma RC; Sharma YN; Arora RB
    Indian J Physiol Pharmacol; 1969 Jul; 13(3):153-5. PubMed ID: 5362630
    [No Abstract]   [Full Text] [Related]  

  • 7. Proposed specification for a reference thromboplastin preparation for the control of anticoagulant therapy using coumarin type drugs.
    Denson KW
    Thromb Diath Haemorrh Suppl; 1967; 26():437-40. PubMed ID: 6064874
    [No Abstract]   [Full Text] [Related]  

  • 8. Standardization of the prothrombin time: clinical results with a recombinant tissue factor reagent.
    Kolde HJ
    Haematologica; 1995; 80(2 Suppl):7-13. PubMed ID: 7628775
    [No Abstract]   [Full Text] [Related]  

  • 9. Considerations on an international standard for the one-stage prothrombin time in the control of anticoagulant therapy.
    Loeliger EA; Hemker HC
    Thromb Diath Haemorrh Suppl; 1968; 35():101-5. PubMed ID: 4953165
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on 4-hydroxy-I-thiacoumarins: VI--anticoagulant activity and chemical structure in 4-hydroxy-I-thiacoumarins and related compounds.
    Jamkhandi PS; Rajagopal S; Sirsi M
    Indian J Exp Biol; 1968 Oct; 6(4):224-6. PubMed ID: 5720680
    [No Abstract]   [Full Text] [Related]  

  • 11. Critical appraisal, clinical usefulness, and implementation of the thromboplastin concept of prothrombin-time standardization.
    Loeliger EA; van den Besselaar AM; Bertina RM
    Scand J Haematol Suppl; 1980; 37():34-48. PubMed ID: 7017900
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacodynamics of the oral anticoagulant drugs.
    O'Reilly RA
    Prog Hemost Thromb; 1974; 2(0):175-213. PubMed ID: 4137288
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticoagulant therapy standards: results of two national surveys.
    Poller L
    Thromb Diath Haemorrh Suppl; 1968; 35():115-2. PubMed ID: 5761059
    [No Abstract]   [Full Text] [Related]  

  • 14. Standardization of laboratory tests for controlling anticoagulent therapy.
    Zucker S; Cathey MH; Sox PJ; Hall EC
    Am J Clin Pathol; 1970 Mar; 53(3):348-54. PubMed ID: 5416772
    [No Abstract]   [Full Text] [Related]  

  • 15. [Standardized prothrombin time test for control of anticoagulant therapy].
    Nilsson IM
    Lakartidningen; 1971 Jun; 68(30):3373-4. PubMed ID: 4106374
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative study of several thromboplastins used to measure the one-stage prothrombin time.
    Littell AS; Ratnoff OD
    Thromb Diath Haemorrh Suppl; 1968; 35():135-48. PubMed ID: 5761061
    [No Abstract]   [Full Text] [Related]  

  • 17. International Normalized Ratio in patients not on vitamin K antagonists.
    Keeling D
    J Thromb Haemost; 2007 Jan; 5(1):188-9. PubMed ID: 17067366
    [No Abstract]   [Full Text] [Related]  

  • 18. Standardization of the one-stage prothrombin time test for the control of anticoagulant therapy: the availability and use of thromboplastin reference preparations.
    Biggs R; Bangham DR
    Am J Clin Pathol; 1972 Jan; 57(1):117-8. PubMed ID: 5008887
    [No Abstract]   [Full Text] [Related]  

  • 19. International Committee for Standardization in Haematology, International Committee on Thrombosis and Haemostasis: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
    Thromb Haemost; 1985 Feb; 53(1):155-6. PubMed ID: 3992515
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study of the anticoagulant properties of 2 derivatives of 4-hydroxycoumarin].
    Thonnart N; Bourgain R; Reuse JJ
    Arch Int Pharmacodyn Ther; 1972 Jun; 197(2):408-11. PubMed ID: 5031151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.